chr15-101292483-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003090.4(SNRPA1):​c.231-443A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.314 in 151,950 control chromosomes in the GnomAD database, including 7,648 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7648 hom., cov: 32)

Consequence

SNRPA1
NM_003090.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0570

Publications

7 publications found
Variant links:
Genes affected
SNRPA1 (HGNC:11152): (small nuclear ribonucleoprotein polypeptide A') Enables RNA binding activity. Involved in mRNA splicing, via spliceosome and spermatogenesis. Located in nuclear speck. Part of U2-type catalytic step 2 spliceosome and U2-type precatalytic spliceosome. Implicated in connective tissue disease. [provided by Alliance of Genome Resources, Apr 2022]
PCSK6 (HGNC:8569): (proprotein convertase subtilisin/kexin type 6) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an initial autocatalytic processing event in the ER to generate a heterodimer which exits the ER and sorts to the trans-Golgi network where a second autocatalytic event takes place and the catalytic activity is acquired. The encoded protease is constitutively secreted into the extracellular matrix and expressed in many tissues, including neuroendocrine, liver, gut, and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. Some of its substrates include transforming growth factor beta related proteins, proalbumin, and von Willebrand factor. This gene is thought to play a role in tumor progression and left-right patterning. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Feb 2014]
PCSK6 Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003090.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNRPA1
NM_003090.4
MANE Select
c.231-443A>G
intron
N/ANP_003081.2P09661
SNRPA1
NR_135506.2
n.152+2614A>G
intron
N/A
SNRPA1
NR_135507.2
n.152+2614A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNRPA1
ENST00000254193.11
TSL:1 MANE Select
c.231-443A>G
intron
N/AENSP00000254193.6P09661
SNRPA1
ENST00000394082.8
TSL:1
n.107+2614A>G
intron
N/A
SNRPA1
ENST00000540017.6
TSL:1
n.159+2614A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.314
AC:
47656
AN:
151834
Hom.:
7641
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.251
Gnomad AMI
AF:
0.182
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.264
Gnomad SAS
AF:
0.346
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.332
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.314
AC:
47692
AN:
151950
Hom.:
7648
Cov.:
32
AF XY:
0.313
AC XY:
23241
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.251
AC:
10394
AN:
41426
American (AMR)
AF:
0.374
AC:
5709
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1190
AN:
3470
East Asian (EAS)
AF:
0.265
AC:
1370
AN:
5178
South Asian (SAS)
AF:
0.349
AC:
1675
AN:
4806
European-Finnish (FIN)
AF:
0.291
AC:
3067
AN:
10524
Middle Eastern (MID)
AF:
0.370
AC:
108
AN:
292
European-Non Finnish (NFE)
AF:
0.343
AC:
23321
AN:
67964
Other (OTH)
AF:
0.329
AC:
692
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1712
3425
5137
6850
8562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.335
Hom.:
4634
Bravo
AF:
0.318
Asia WGS
AF:
0.284
AC:
987
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
9.3
DANN
Benign
0.84
PhyloP100
-0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4965818; hg19: chr15-101832688; API